CSL share price edges up as buyback keeps ASX heavyweight in play

CSL Ltd edged 0.6% higher to finish at A$146.02 on Thursday, bouncing between A$145.18 and A$147.15 during the session. The stock remains just above its 52-week low of A$144.61, well off the A$275.79 high.

26 February 2026

Why CSL’s share price is moving: Lilly clazakizumab deal, buyback pace and the next dividend date

CSL Limited finished Thursday’s session at A$154.19, up 0.95%. Shares bounced between A$152.13 and A$154.45 during the day. While that makes two days in positive territory, the stock is still roughly 15% off its early-February highs.

19 February 2026

ASX:CSL.AX·Dividends·Pharmaceuticals·Stock Market

CSL shares slide as CEO Paul McKenzie retires, Gordon Naylor named interim ahead of results

CSL announced Tuesday that Chief Executive Paul McKenzie is stepping down, with Gordon Naylor stepping in as interim CEO and managing director beginning Feb. 11. McKenzie, who came aboard as chief operating officer in 2019, moved up to the CEO post in March 2023. During his tenure, CSL rolled out new treatments, including Hemgenix, its gene therapy for haemophilia B. Naylor, previously finance chief and head of the Seqirus vaccines division, took a board seat in December.

10 February 2026

ASX:CSL.AX·Pharmaceuticals·Stock Market

CSL share price slips after the close as investors zero in on Feb 11 results

CSL Ltd edged down 0.07% to A$180.37 on Monday, changing hands roughly 502,000 times. Shares started the day at A$180.90, peaked at A$182.54, and touched a low of A$179.97. Over the past year, the stock has dropped around 33%.

9 February 2026

ASX:CSL.AX·Earnings Reports·Stock Market

CSL Limited stock in focus: what to watch before Monday as half-year results loom

CSL Ltd closed out Friday at A$180.50, slipping 0.4%. The day saw shares kick off at A$182.80 before moving between A$179.29 and A$183.31. Volume landed around 1.23 million shares as attention turned to the biotech’s upcoming half-year results and the unsettled market mood.

8 February 2026

ASX:CSL.AX·Earnings Reports·Stock Market

CSL share price slips as results loom — what investors watch next week

CSL Limited shares slipped 0.25% to close at A$181.24 on Thursday, erasing some early gains. Investors appeared focused on next week’s half-year results rather than the day’s action. The stock fluctuated between A$180.92 and A$184.02, remaining roughly a third below its 52-week peak.

5 February 2026

ASX:CSL.AX·Earnings Reports·Stock Market

CSL share price ends higher after Vanguard lifts stake — here’s what to watch next

CSL Limited finished the day 1.13% higher, closing at A$181.42, up A$2.02. During the session, shares fluctuated between A$181.00 and A$184.41. Over the past year, the stock has swung from a low of A$168.00 to a high of A$282.20.

31 January 2026

ASX:CSL.AX·Stock Market

CSL share price slips after CPI surprise — what to watch before Feb 11 results

CSL Ltd shares dipped 1.15% to A$180.19 Wednesday, after trading as high as A$184.35 and as low as A$179.40. Around 658,000 shares exchanged hands. The stock had climbed 1.49% the previous session.

28 January 2026

ASX:CSL.AX·Earnings Reports·Stock Market

CSL share price rises after ASX rally — what investors watch before Feb 11 results

CSL Ltd shares ended Thursday roughly 0.9% higher, closing at A$177.71. The healthcare giant is regaining footing following a tough 2025.

22 January 2026

ASX Updates·ASX:CSL.AX·Stock Market

CSL Limited stock rises 1% on the ASX — what investors are watching next

Shares of CSL Ltd closed Thursday 1.03% higher at A$175.28, swinging between A$174.21 and A$176.68 during the session. Volume hovered around 630,000 shares, matching typical recent activity.

15 January 2026

ASX News·ASX:CSL.AX·Stock Market

CSL share price ticks higher — but the real test is Feb 11

CSL Ltd shares closed up 0.46% at A$175.10 on Monday, adding 81 Australian cents from Friday’s close, according to market data. About 376,000 shares traded.

12 January 2026

ASX:CSL.AX·Stock Market

CSL share price rebounds as inflation cools; ASX:CSL turns to February results and RBA call

CSL Ltd shares closed up 1.0% at A$170.00 on Wednesday. The biotech heavyweight recovered some ground after sliding 2.4% in the prior session as Australian stocks steadied after a softer inflation reading. The stock traded between A$168.65 and A$170.52 and is down about 41% over the past year, hovering near its 52-week low of A$168.00. Investing.com Australia

7 January 2026

ASX Updates·ASX:CSL.AX·Inflation·Stock Market

Why CSL’s share price is moving: Lilly clazakizumab deal, buyback pace and the next dividend date

CSL shares slide as CEO Paul McKenzie retires, Gordon Naylor named interim ahead of results

CSL share price slips after the close as investors zero in on Feb 11 results

CSL Limited stock in focus: what to watch before Monday as half-year results loom

CSL share price slips as results loom — what investors watch next week

CSL share price ends higher after Vanguard lifts stake — here’s what to watch next

CSL share price slips after CPI surprise — what to watch before Feb 11 results

CSL share price rises after ASX rally — what investors watch before Feb 11 results

CSL Limited stock rises 1% on the ASX — what investors are watching next

CSL share price ticks higher — but the real test is Feb 11

CSL share price rebounds as inflation cools; ASX:CSL turns to February results and RBA call

TechStock² Updates

Ondas Shares Drop 9.7% After Reporting $50.6 Million EBITDA Loss Despite $757 Million Backlog

IREN shares drop 12.5% after $4 billion AI contract announcements coincide with $703 million annual loss

Nvidia Stock Falls 4.6%, Erasing $251 Billion as Margin Guide Tests AI Rally

Flutter shares climb 7.1% as FanDuel’s $350 promotion puts spotlight on marketing spend

DraftKings Bonus Incentive Drives Marketing Costs to 22% of Revenue; Shares Gain 4.3%

SpaceX Starship Flight 14 Slips to September as $1.85 Trillion Valuation Awaits Orbital Test

PG&E Shares Drop 7.5% After Wildfire Liability Deal Fails, Wiping Out $3 Billion

Intel Stock Falls 2.9% as 14A Defect Gains Confront $2.1 Billion Foundry Loss

Ford Shares Slip 0.5% as Threat of Canada Tariffs Challenges 7.5x Earnings Valuation

Salesforce Shares Lift 1.6% on 2.3x Volume as AI Surge Tests Analyst Price Targets

Investment Disclaimer